John Theurer Cancer Center at Hackensack is a clinical research site located in Hackensack, New Jersey, United States 07601.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
John Theurer Cancer Center at Hackensack has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Leukemia, Myeloid, Acute, Prostate Cancer, Metastatic Pancreatic Ductal Adenocarcinoma.
Sponsors: Astex Pharmaceuticals, Inc., Dendreon, Agenus Inc..
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
John Theurer Cancer Center at Hackensack has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
John Theurer Cancer Center at Hackensack has 3 clinical trials on record, with 1 currently active. Their work covers Leukemia, Myeloid, Acute, Prostate Cancer, Metastatic Pancreatic Ductal Adenocarcinoma.
John Theurer Cancer Center at Hackensack has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.